Lupin Limited has informed the Exchange regarding a press release dated Jun 17, 2021, titled "Lupin Receives U.S. FDA Approval for Sevelamer Hydrochloride Tablets".
Lupin Limited has informed the Exchange regarding a press release dated Jun 17, 2021, titled "Lupin Receives U.S. FDA Approval for Sevelamer Hydrochloride Tablets".